Skip to main content

Table 4 Syndromic and definitive diagnoses γ according to WHO stages and ANRS degrees of severity, in HIV-infected adults receiving antiretroviral treatment, IeDEA West Africa, December 2009 to December 2011

From: Severe morbidity after antiretroviral (ART) initiation: active surveillance in HIV care programs, the IeDEA West Africa collaboration

Diagnoses, number

Total

 

WHO classification

ANRS degrees of severity

Hospitalisation*

Death**

 

N = 1675

(%)

Stage 3

Stage 4

Degree 3

Degree 4

  

Infectious events

        

Parasitic events

        

   Malaria

359

(24.8)

  

99

12

127

 

   Cerebral toxoplasmosis

24

(1.7)

0

24

  

15

3

   Other parasitic events

9

(0.6)

 

3

1

 

2

 

Bacterial events

        

   Pneumonia

194

(13.4)

194

   

79

2

   Tuberculosis

111

(7.7)

45

66

  

43

4

   ENT infection

26

(1.8)

  

2

 

3

 

   Severe bacterial infection

17

(1.2)

17

   

7

1

Other eventsβ

12

(0.8)

  

2

2

3

 

Mycotic events

        

   Oral candidiasis

138

(9.5)

133

   

8

 

   Other mycoses£

25

(1.7)

 

11

  

1

 

Infectious diarrhoea

121

(8.4)

  

45

12

75

 

Skin infections

16

(1.1)

  

1

 

5

 

Viral infections π

35

(2.4)

 

25

1

 

15

1

Other infectious events α

27

(1,9)

  

5

4

10

 

Non infectious diagnosis

        

   Peripheral neuropathy***

52

(3.6)

  

39

5

5

 

   Toxiderma

19

(1.3)

  

6

7

11

 

   Tumors

17

(1.2)

 

11

 

1

9

 

   Other non infectious diagnosesΨ

46

(3.2)

  

8

17

13

1

Non specific events

        

   Anemia

164

(11.3)

  

57

82

84

3

   Fever

49

(3.4)

 

4

9

4

10

1

   Diarrhoea

25

(1.7)

 

5

11

1

18

2

   Other general signsθ

57

(3.9)

  

23

16

41

2

   Other non specificф

31

(2.1)

  

7

5

32

3

Death

101

       
  1. ENT = Ear Nose Throat.
  2. γ Several diagnoses for a same event.
  3. *Number of events with at least one day in day care.
  4. ** Number of death occurring after the event.
  5. *** including 37 neuropathies secondary to ART initiation.
  6. (%) Percentage calculated based on the number of events.
  7. including 54 anaemia secondary to a treatment.
  8. 6 ameibiasis, 2 pneumocystoses, 1 microsporidia.
  9. β9 urinary infections, 2 appendicites, 1 cholecystitis.
  10. £11 vaginal candidosis, 10 oesophagal candidosis, 3 digestive candidosis, 1 cryptococcal.
  11. π21 HIV-related cachexia syndrome, 8 herpes zoster, 4 HIV-related encephalopathies, 2 herpes.
  12. Tumors: 9 kaposi, 4 benign tumors, 2 unkown evolutive tumors, 1 cervical cancer, 1 Non-Hodgkin malignant Lymphoma.
  13. Ψ Cardio-vascular (6 arterial hypertension, 4 peripheral veins, 2 stroke), Renal (6 nephropathy, 6 renal failure), metabolic (5 abnormal fat distribution, 1 lactic acidosis, 1 diabetes), Genito-obstetric (two abortions, two other), Gastrointestinal (3 gastric or duodenal ulcers, 1 chronic pancreatitis, 7 other.
  14. α7 genital infections, 6 osteoarticular infections, 6 broncho-pneumopathy, 5 meningitis, 2 stomatitis, 1 hepatitis.
  15. θ19 asthenia, 21 dehydration, 17 under-nutrition.
  16. Ф1 digestive disorders, 6 hemiplegia/tetraplegia, 6 psychiatric signs, 5 neutropenia, 2 liver signs, 11 other signs.